Family Medicine · Burbank, IL
NPI
1912444209
Since 2017
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4817 W 83rd St
Burbank, IL, 60459
Phone (708) 262-4876
Groups this clinician bills Medicare through
Medicare paid, 2024
$380K
4,506 services
Medicare patients, 2024
388
Average age 75
Drug cost, 2024
$752K
11,517 prescriptions
Company payments, 2025
$346
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Husam M Ali was code 99309 (snf e&m), 2,201 times for 311 patients. In total Husam M Ali billed 4,506 services in 27 codes, and Medicare paid $380K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Facility | 2,201 | 311 | $88.11 | $194K |
| 99308 SNF E&M | Facility | 1,130 | 212 | $60.70 | $69K |
| 99232 Hospital E&M - Subsequent | Facility | 348 | 51 | $64.70 | $23K |
| 99306 SNF E&M | Facility | 233 | 217 | $148.50 | $35K |
| 99233 Hospital E&M - Subsequent | Facility | 149 | 21 | $97.58 | $15K |
| 99310 SNF E&M | Facility | 119 | 53 | $126.27 | $15K |
| 99238 Hospital Discharge Management | Facility | 61 | 41 | $66.27 | $4,042 |
| 99305 SNF E&M | Facility | 55 | 51 | $109.00 | $5,995 |
| 99222 Hospital E&M - Initial | Facility | 42 | 33 | $107.76 | $4,526 |
| 99223 Hospital E&M - Initial | Facility | 41 | 28 | $142.45 | $5,841 |
| 99214 Office E&M - Established | Office | 35 | 14 | $102.41 | $3,584 |
| 99315 SNF E&M | Facility | 29 | 29 | $66.70 | $1,934 |
| 99316 SNF E&M | Facility | 12 | 11 | $107.06 | $1,285 |
By year: 2022 $289K for 4,447 services; 2023 $230K for 3,161 services; 2024 $380K for 4,506 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $2.96 | $38.46 |
Medicare prescription drug claims, 2024
In 2024, the drug Husam M Ali prescribed most often to Medicare patients was Atorvastatin Calcium, with 731 prescriptions and refills. In total Husam M Ali wrote 11,517 Medicare prescriptions that cost $752K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 731 | 763 | 142 | $9,719 |
| Eliquis Apixaban | 535 | 543 | 54 | $130K |
| Amlodipine Besylate Generic | 429 | 452 | 85 | $3,831 |
| Tamsulosin Hcl Generic | 288 | 296 | 37 | $2,481 |
| Gabapentin Generic | 283 | 297 | 59 | $5,278 |
| Levothyroxine Sodium Generic | 280 | 282 | 41 | $2,521 |
| Pantoprazole Sodium Generic | 252 | 270 | 72 | $4,899 |
| Omeprazole Generic | 241 | 249 | 40 | $2,123 |
| Furosemide Generic | 232 | 240 | 55 | $1,398 |
| Metoprolol Tartrate Generic | 226 | 231 | 49 | $2,052 |
| Sertraline Hcl Generic | 209 | 209 | 30 | $2,414 |
| Lisinopril Generic | 208 | 214 | 46 | $2,386 |
| Levetiracetam Generic | 206 | 206 | 24 | $4,201 |
| Metformin Hcl Generic | 204 | 228 | 43 | $1,723 |
| Trazodone Hcl Generic | 176 | 178 | 36 | $2,425 |
Brand drugs: 1,693 claims; generic drugs: 9,801 claims; opioid claims: 192.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Husam M Ali $346 ($346 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $89.15.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 4 | $89.15 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $88.25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $40.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $37.56 |
| Abbvie Inc. ABBV | 1 | $26 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $24.82 |
| Exact Sciences Corporation EXAS | 1 | $24.61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $15.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.